Dr. Peter T. Dziegielewski, MD

Dr. Dziegielewski practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Dziegielewski's NPI, 1013287101, was assigned on January 5, 2012. Dr. Dziegielewski graduated from University of Alberta in 2007. Dr. Dziegielewski holds Florida license ME116212.

Dr. Dziegielewski's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Dziegielewski's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Dziegielewski to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dziegielewski practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Dziegielewski's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Dziegielewski is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Dziegielewski's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists endoscopic sinus surgery, larynx and vocal cord disease and thyroid surgery among the conditions Dr. Dziegielewski treats.

CMS data shows 883 Medicare services from Dr. Dziegielewski across 12 procedure codes in 2024, for 374 Medicare patients. Medicare paid $127,781 for them.

CMS counts 374 Medicare patients who saw Dr. Dziegielewski in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dziegielewski's median patient age at 73, with 40% women.

In 2024, Dr. Dziegielewski wrote 94 Medicare Part D claims for 44 patients. 93% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $99 in total drug cost. In 2022, CMS named 55 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dziegielewski for performance year 2024, reported individually. Dr. Dziegielewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of melanoma (skin cancer) excision by Dr. Dziegielewski, more than 67% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 129 papers to Dr. Dziegielewski, published from 2010 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Plastic Surgery Procedures. Dr. Dziegielewski has published most often in Head Neck. Dr. Dziegielewski's most frequent co-authors are Robert J. Amdur, MD, William M. Mendenhall, MD and Brian Boyce, MD.

CMS Open Payments shows 51 general payments to Dr. Dziegielewski from 6 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 50% of the total. Medical Device Business Services, Inc. paid the most, $8,930.

Dr. Dziegielewski graduated from University of Alberta in 2007.

Dr. Dziegielewski is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.